Sector Inquiry

The European Commission Presents Its Preliminary Findings

D. Schnichels, E. Kamilarova, European Commission, Belgium

page 10

Pharma Trends

The Role of the Knowledge Management Platform

R. Fitzmartin, J. Wise, Daiichi Sankyo, USA

page 12

Characterizing Molecular Interactions

Label-free, Back-Scattering Interferometry

D.J. Bornhop et al., Vanderbilt University, USA

page 14

Advancing Academic Drug Discovery

A Collaborative Model Involving Two Germany-based Organizations

M. Grättinger et al., European ScreeningPort, Germany

page 17

Flexible Automatic Image Analysis and Interpretation of Cell Pattern

P. Perner, Institute of Computer Vision and applied Computer Sciences, IBaI, Germany

page 20

Preclinical Drug Development

Proof-of-Concept in the Force Field of Efficacy and Safety

K. Syha, Syha Consult, Germany

page 22

High-Field Asymmetric Waveform Ion Mobility Spectrometry

J. Horner, J. Phillips, Thermo Fisher Scientific, USA

page 26

Cell Surface Receptors’ Study and Screening

New HTRF Cellular Platform
J.-L.-Tardieu, Cisbio Bioassays, France

page 28

Bio-High-Tech

Lab-on-a-Chip, Molecular Diagnostics Europe and Advances in Microarray Technology

A. Woodley

page 8

Pharma Outsourcing Summit

A One-day Symposium

page 9

Biomanufacturers Gather in Dusseldorf to Debate the Industry

page 9